Atherosclerotic heart disease. Atherosclerotic heart disease
Conditions
Interventions
Intervention 1: Intervention group: recieved Heparin infiusion for 6-12h after successful PCI for 1000Unit/hr. Intervention 2: Control group:recieved daily aspirin for 80mg and 400mg plavix befor PCI
Treatment - Drugs
Intervention group: recieved Heparin infiusion for 6-12h after successful PCI for 1000Unit/hr
Control group:recieved daily aspirin for 80mg and 400mg plavix befor PCI and 75mg daily aspirin for 6M
Sponsors
Vice-chancellery of Research Affairs, Shiraz university of medical science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients who had a successful PCI Exclusion criteria: 1) Acute MI 2) Complicated PCI
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In hospital major or minor bleeding. Timepoint: in hospital. Method of measurement: by observing the markers.;Vascular events. Timepoint: in hospital. Method of measurement: by observing the markers. | — |
Secondary
| Measure | Time frame |
|---|---|
| In hospital ischaemic complications. Timepoint: in hospital. Method of measurement: by observing the MI, emergency CABG, repeat PCI, abrupt closure. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactzahra Daneshvar
Cardiovascular Research Center, Shiraz university of medical sciense
Outcome results
None listed